LFCR
NASDAQ
US
Lifecore Biomedical, Inc. - Common Stock
$3.84
▲ +$0.00
(+0.00%)
Vol 602K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$306.5M
ROE
-67.9%
Margin
-24.0%
D/E
369.57
Beta
0.63
52W
$5–$9
Wall Street Consensus
11 analysts · Apr 20264
Strong Buy
4
Buy
3
Hold
0
Sell
0
Strong Sell
72.7%
Buy Rating
Price Chart
Similar Stocks
ATLN
Atlantic International Corp
$77.8M
QTRX
Quanterix Corp
$297.1M
TKNO
Alpha Teknova Inc
$203.4M
CDXS
Codexis Inc
$147.2M
QSI
Quantum-Si Inc
$237.0M
SEER
Seer Inc
$102.1M
RPID
Rapid Micro Biosystems Inc
$128.5M
CSBR
Champions Oncology Inc
P/E 32.5
$96.0M
MXCT
MaxCyte Inc
$165.3M
HYFT
MindWalk Holdings Corp
$85.0M
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Jun 2025 | $-0.10 | $-0.06 | +$0.04 |
| Mar 2025 | $-0.15 | $-0.47 | $-0.32 |
| Dec 2024 | $-0.30 | $-0.25 | +$0.05 |
| Sep 2024 | $-0.47 | $-0.49 | $-0.02 |
Fundamentals Trend
| Metric | 2025-05-25 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -79.8% | -89.0% | -79.8% | -79.8% | -67.9% | -67.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -3.1% | -34.3% | -30.0% | -30.0% | -24.0% | -24.0% |
| Gross Margin | 38.4% | 33.5% | 31.3% | 31.3% | 31.6% | 31.6% |
| D/E Ratio | 267.75 | 263.44 | 267.75 | 267.75 | 369.57 | 369.57 |
| Current Ratio | 2.84 | 2.71 | 2.84 | 2.84 | 2.80 | 2.80 |
Key Ratios
ROA (TTM)
-13.4%
P/S (TTM)
2.27
P/B
5.2
EPS (TTM)
$-0.89
CF/Share
$-1.85
Rev Growth 3Y
-11.5%
52W High
$8.85
52W Low
$4.76
$4.76
52-Week Range
$8.85
How does LFCR compare to Life Sciences Tools & Services peers?
Peer group: Small-cap Life Sciences Tools & Services ($300M+) · 25 companies
LFCR valuation vs Life Sciences Tools & Services peers
P/E ratio
—
▼
0%
below
peers
(32.5)
vs Peers
vs Industry
Fair value
P/S ratio
2.3
▼
41%
below
peers
(3.8)
vs Peers
vs Industry
Undervalued
P/B ratio
5.3
▲
41%
above
peers
(3.7)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.5%)
vs Peers
vs Industry
Low yield
LFCR profitability vs Life Sciences Tools & Services peers
ROE
-67.9%
▼
1976%
below
peers
(-3.3%)
vs Peers
vs Industry
Weak
Net margin
-24.0%
▼
156%
below
peers
(-9.4%)
vs Peers
vs Industry
Weak
Gross margin
31.6%
▼
34%
below
peers
(48.0%)
vs Peers
vs Industry
Weak
ROA
-13.4%
▼
417%
below
peers
(-2.6%)
vs Peers
vs Industry
Weak
LFCR financial health vs Life Sciences Tools & Services peers
D/E ratio
369.6
▲
912%
above
peers
(36.5)
vs Peers
vs Industry
High debt
Current ratio
2.8
▼
17%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
0.6
▼
55%
below
peers
(1.4)
vs Peers
vs Industry
More volatile
LFCR fundamentals radar
LFCR
Peer median
Industry
LFCR profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio